195 related articles for article (PubMed ID: 28117555)
1. Biomarker classification, validation, and what to look for in 2017 and beyond.
Davis JW
BJU Int; 2017 May; 119(5):812-814. PubMed ID: 28117555
[No Abstract] [Full Text] [Related]
2. The role of immunotherapy for urological tumours.
Hrouda D; Muir GH; Dalgleish AG
Br J Urol; 1997 Mar; 79(3):307-16. PubMed ID: 9117206
[No Abstract] [Full Text] [Related]
3. The role of immunotherapy in urologic malignancies.
Abubakr YA; Redman BG
Cancer Treat Res; 1996; 88():235-48. PubMed ID: 9239484
[No Abstract] [Full Text] [Related]
4. [Utility of the serum CRP value for assessing the prognosis and therapeutic response of urological malignancies].
Köhler A; Eggers H; Kuczyk MA; Schrader AJ; Steffens S
Aktuelle Urol; 2013 Nov; 44(6):452-5. PubMed ID: 24258396
[TBL] [Abstract][Full Text] [Related]
5. The evolving role of cytoreductive surgery for metastatic renal cell carcinoma.
Chaudhary UB; Hull GW
Oncology (Williston Park); 2003 May; 17(5):701-5; discussion 705-6, 711-2. PubMed ID: 12800795
[TBL] [Abstract][Full Text] [Related]
6. [Biological response modifiers and urological cancer].
Ohmori H; Tazaki H
Nihon Hinyokika Gakkai Zasshi; 1992 Jun; 83(6):850-6. PubMed ID: 1501395
[No Abstract] [Full Text] [Related]
7. [Are immunotherapy and chemotherapy in metastatic renal cell cancer out?].
Schmitz-Dräger BJ
Urologe A; 1992 Jul; 31(4):213-4. PubMed ID: 1514204
[No Abstract] [Full Text] [Related]
8. Present status of cancer treatment in Singapore-management of urological cancers.
Tun KH; Tan EC; Foo KT
Gan To Kagaku Ryoho; 1992 Jul; 19(8 Suppl):1139-45. PubMed ID: 1514826
[No Abstract] [Full Text] [Related]
9. [Current modalities in immunotherapy of renal cell carcinoma].
Aliaev IuG; Grigorian VA; Shpot' EV
Ter Arkh; 2007; 79(6):78-82. PubMed ID: 17684975
[No Abstract] [Full Text] [Related]
10. Metastasectomy plus immunotherapy compared with immunotherapy alone in metastatic renal cell carcinoma.
Ku JH; Kwak C
Clin Oncol (R Coll Radiol); 2007 Mar; 19(2):164-5. PubMed ID: 17355116
[No Abstract] [Full Text] [Related]
11. Pseudoprogression and hyperprogression during immune checkpoint inhibitor therapy for urothelial and kidney cancer.
Soria F; Beleni AI; D'Andrea D; Resch I; Gust KM; Gontero P; Shariat SF
World J Urol; 2018 Nov; 36(11):1703-1709. PubMed ID: 29549485
[TBL] [Abstract][Full Text] [Related]
12. Systemic Treatments for Metastatic Renal Cell Carcinoma: 10-Year Experience of Immunotherapy and Targeted Therapy.
Kim SH; Park WS; Kim SH; Joung JY; Seo HK; Lee KH; Chung J
Cancer Res Treat; 2016 Jul; 48(3):1092-101. PubMed ID: 26875203
[TBL] [Abstract][Full Text] [Related]
13. Predicting response to interleukin-2 therapy among patients with renal cell carcinoma.
Leppert JT; Lam JS; Belldegrun AS
J Immunother; 2005; 28(5):427-9. PubMed ID: 16113598
[No Abstract] [Full Text] [Related]
14. Better survival with interleukin-2-based regimens? Possibly only in highly selected patients.
Négrier S
J Clin Oncol; 2004 Apr; 22(7):1174-6. PubMed ID: 14981101
[No Abstract] [Full Text] [Related]
15. Prognostic factors in renal cell cancer.
Park WH; Eisen T
BJU Int; 2007 May; 99(5 Pt B):1277-81. PubMed ID: 17441924
[No Abstract] [Full Text] [Related]
16. Integration of surgery and systemic therapy for renal cell carcinoma.
Kenney PA; Wood CG
Urol Clin North Am; 2012 May; 39(2):211-31, vii. PubMed ID: 22487764
[TBL] [Abstract][Full Text] [Related]
17. Pyruvate kinase type tumor M2 in urological malignancies.
Hegele A; Varga Z; Kosche B; Stief T; Heidenreich A; Hofmann R
Urol Int; 2003; 70(1):55-8. PubMed ID: 12566817
[TBL] [Abstract][Full Text] [Related]
18. Potential role for metformin in urologic oncology.
Sayyid RK; Fleshner NE
Investig Clin Urol; 2016 May; 57(3):157-64. PubMed ID: 27195314
[TBL] [Abstract][Full Text] [Related]
19. Renal cell carcinoma: urologists in a new era.
Uzzo RG
J Urol; 2005 Nov; 174(5):1723-4. PubMed ID: 16217270
[No Abstract] [Full Text] [Related]
20. [Update on the medical treatment of urologic tumors].
Culine S
Bull Cancer; 2000 Jan; 87(1):71-5. PubMed ID: 10673634
[No Abstract] [Full Text] [Related]
[Next] [New Search]
